U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863960) titled 'Efficacy and Safety of Photobiomodulation for Postoperative Pain After Cesarean Section' on Oct. 01.

Brief Summary: Postoperative pain following cesarean section remains a major clinical challenge that can impair early maternal recovery, delay ambulation, and interfere with newborn care. Photobiomodulation (PBM) is a non-invasive light therapy that uses red and near-infrared light to reduce inflammation, stimulate cellular energy (ATP) production, and promote tissue repair. The purpose of this randomized, double-blind, sham-controlled clinical trial is to evaluate the efficacy and safety of portable photobiomodulation using the MitoQ...